Brazil enjoyed a rare glimmer of hope last weekend, as the first coronavirus vaccinations were administered in the country. However, government officials have warned that immunization may face a 30-to-40-day stoppage, due to a lack of vaccine stocks. Indeed, Brazil is a long way away from being able to offer inoculation to its 211 million inhabitants. It is in this scenario of slim pickings that the Russian-made Sputnik V vaccine has emerged as a potential option for immunizing the Brazilian population.
Constantly dismissed by the government of far-right President Jair Bolsonaro, Sputnik V is gradually becoming a suitable candidate, but lacks regulatory approval.